Clinical Trials Directory

Trials / Unknown

UnknownNCT00175942

Risk Indicators in Patients With Ventricular Fibrillation During Acute Myocardial Infarction

Indicators of Coagulation Activation and Inflammation Contributing to Ventricular Fibrillation Complicating Acute Myocardial Infarction

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (planned)
Sponsor
Heidelberg University · Academic / Other
Sex
All
Age
0 Years
Healthy volunteers
Not accepted

Summary

Sudden cardiac death is in most cases triggered by ischemia-related ventricular tachyarrhythmias and accounts for 50% of deaths from cardiovascular disease in developed countries. Chronic elevation of indicators of coagulation activation has been found in patients with coronary heart disease , but a role of coagulation activation and proinflammatory state as a potential risk factor for ventricular fibrillation (VF) during acute myocardial infarction has not been investigated.

Detailed description

Sudden cardiac death (SCD) is in most cases triggered by ischemia-related ventricular arrhythmias and is responsible for 50% of the mortality from cardiovascular disease in developed countries (1). Chronic elevation of indicators of coagulation activation and inflammation has been found in patients with coronary heart disease and may contribute to vasculatory disorders probably contributing to the development of arrhythmogenesis. However, the role of coagulation activation as a potential risk factor for ventricular fibrillation during acute myocardial infarction has not been investigated yet.

Conditions

Timeline

Start date
2003-02-01
First posted
2005-09-15
Last updated
2005-09-15

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00175942. Inclusion in this directory is not an endorsement.